Omalizumab or dupilumab suggested for adults with moderate-to-severe allergic asthma, history of exacerbations requiring oral corticosteroids ...
The new generic drug has been approved for treatment of bovine respiratory disease and associated pyrexia in beef and ...
That price equates to an aggregate equity value of $2.2 billion, according to GSK, who added that the upfront investment net ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results